AmerisourceBergen Executive Vice President of Retail Strategy and President of Good Neighbor Pharmacy David W. Neu to Retire

Brian Nightengale, RPh, PhD, President of Xcenda to assume role as
President of Good Neighbor Pharmacy

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Apr. 22, 2016--
AmerisourceBergen Corporation (NYSE: ABC) today announced that David W.
Neu, Executive Vice President of Retail Strategy and President of Good
Neighbor Pharmacywill retire in the summer of 2016. Neu has served
AmerisourceBergen for more than 30 years in an array of leadership roles
including heading the AmerisourceBergen Drug Corporation. During his
tenure with the company, Neu has passionately championed the value of
independent community pharmacy to the health and pharmaceutical
industry. Neu’s leadership extends beyond AmerisourceBergen to numerous
industry organizations including his appointment as Board of Directors
Chairman for the Healthcare Distribution Management Association in 2012
and his election to the board of the National Association of Chain Drug
Stores in 2015.

“Our company will continue to be inspired by Dave, and his legacy will
be AmerisourceBergen’s unwavering focus on providing innovative and
impactful support to community pharmacists,” said Steven H. Collis,
AmerisourceBergen’s Chairman, President and Chief Executive Officer.
“Dave has been a true friend and mentor to many including me. He has
inspired so many of us with his tremendous energy, dedication to our
customers and an approachable manner that has motivated associates at
every level of our organization.”

Brian Nightengale, RPh, PhD, President of Xcenda will immediately assume
the role of President of Good Neighbor Pharmacy. Nightengale has
more than 20 years of experience with Xcenda, a part of
AmerisourceBergen, leading efforts to demonstrate the value of
pharmaceutical products while improving patient access to medications.
As an original Xcenda employee, Nightengale played a key role in growing
the company from a startup to a global leader in commercialization
support for innovative medical treatments. Prior to joining Xcenda,
Nightengale served as an Assistant Professor at the College of Pharmacy,
University of Oklahoma Health Sciences Center where he is currently a
member of the National Board of Advisors.

“In today’s healthcare landscape, independent pharmacists are seeking
partners who can help grow their business and their ability to meet the
needs of patients in communities across the country,” said Robert P.
Mauch, PharmD, PhD, President of AmerisourceBergen Drug Corporation.
“Brian’s pharmacy background, deep understanding of the payer
environment and clinical and commercial expertise will offer exciting
new perspective for Good Neighbor Pharmacyand will enable us to
honor Dave’s legacy by building the capabilities and solutions we need
to support independent community pharmacists.”

About AmerisourceBergen

AmerisourceBergen is one of the largest global pharmaceutical sourcing
and distribution services companies, helping both healthcare providers
and pharmaceutical and biotech manufacturers improve patient access to
products and enhance patient care. With services ranging from drug
distribution and niche premium logistics to reimbursement and
pharmaceutical consulting services, AmerisourceBergen delivers
innovative programs and solutions across the pharmaceutical supply
channel in human and animal health. With over $135 billion in annual
revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and
employs approximately 18,000 people. AmerisourceBergen is ranked #16 on
the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..